TOPICAL B-BLOCKER SIDE EFFECTS IN ELDERLY
TOPICAL B-BLOCKER SIDE EFFECTS IN ELDERLY
批准号:
3264735
负责人:
JEROME L AVORN
金额:
$16.04万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 1991-06-30
关键词:
Medicare /Medicaid beta antiadrenergic agent chemical information system chronic disease /disorder disease /disorder proneness /risk drug adverse effect drug tolerance epidemiology eye agent glaucoma human morbidity human old age (65+) medical indigency nonhuman therapy evaluation ocular hypotensive toxicology information system
中文摘要
局部应用受体阻滞剂是青光眼的主要治疗方法
英文摘要
Topically applied beta-blockers are a mainstay of glaucoma
treatment. While there exist good data concerning the efficacy of
topical beta-blockers in reducing intraocular pressure, very little
is known about the epidemiology of systemic adverse effects from
this common therapy, particularly in the elderly.
This study will analyze the pharmaco-epidemiology of ophthalmic
beta-blocker side effects in a population of over 1 million
patients in New Jersey, through computer-assisted investigation of
a dataset of all recipients in the New Jersey Medicaid program
(N=975,700), as well as int the Pharmacy Assistance for the Aged
and Disabled program (PAAD) (N=250,000). These complete records
of medication use data and all other reimbursed health care
services (including office visits, emergency services,
hospitalizations, and long-term care) will be tracked on a patient-
specific basis and supplemented with all Medicare claims data
(Parts A and B, also on a person-specific basis).
Epidemiologic analysis will take the form of follow-up (cohort)
studies, after exposure to an ophthalmic beta-blocker, either
timolol or betaxolol. Outcomes of interest will be the rate of
health care encounters for clinical events such as congestive heart
failure, bronchospasm, depression, or confusion. These will be
tracked not only by measures such as physician visits or hospital
stays, but also by tracing the pattern of use of medications
prescribed to treat these conditions (e.g. diuretics, digoxin,
bronchodilators, antidepressants, etc.). Standard epidemiologic
techniques will be used to answer the following questions: (1) Is
there an increased risk of the systemic side effects studied in
glaucoma patients using topical beta-blockers, and what is the
magnitude of such risk? (2) Are there important co-factors that
predict elevated risk among certain subgroups of glaucoma
patients, such as age, specific comorbidity, co-existing medication
use, etc.? (3) Is there a clinically important difference between
betaxolol and timolol in regard to the outcomes studied? (4) If
differences in adverse effect risk are found in patients using
these medications, what are its implications for practice in the
care of glaucoma patients?
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DRUGS AND AGING--DEMOGRAPHIC, CLINICAL, AND COST DATA
-
批准号:6190122
-
项目类别:
-
资助金额:$8.48万
-
财政年份:2000
-
负责人:JEROME L AVORN
-
依托单位:
RISKY GERIATRIC BENZODIAZEPINE USE--PREDICTORS & TRENDS
-
批准号:2488631
-
项目类别:
-
资助金额:$4.14万
-
财政年份:1996
-
负责人:JEROME L AVORN
-
依托单位:
RISKY GERIATRIC BENZODIAZEPINE USE--PREDICTORS & TRENDS
-
批准号:2517966
-
项目类别:
-
资助金额:$26.94万
-
财政年份:1996
-
负责人:JEROME L AVORN
-
依托单位:
RISKY GERIATRIC BENZODIAZEPINE USE--PREDICTORS & TRENDS
-
批准号:2013418
-
项目类别:
-
资助金额:$24.16万
-
财政年份:1996
-
负责人:JEROME L AVORN
-
依托单位:
NEPHROLOGIST CARE AND OUTCOMES IN RENAL INSUFFICIENCY
-
批准号:2546250
-
项目类别:
-
资助金额:$30.7万
-
财政年份:1996
-
负责人:JEROME L AVORN
-
依托单位:
NEPHROLOGIST CARE AND OUTCOMES IN RENAL INSUFFICIENCY
-
批准号:2032201
-
项目类别:
-
资助金额:$33.2万
-
财政年份:1996
-
负责人:JEROME L AVORN
-
依托单位:
DRUG-INDUCED PARKINSONIAN SYMPTOMS IN THE ELDERLY
-
批准号:3121537
-
项目类别:
-
资助金额:$7.82万
-
财政年份:1991
-
负责人:JEROME L AVORN
-
依托单位:
DRUG-INDUCED PARKINSONIAN SYMPTOMS IN THE ELDERLY
-
批准号:3121534
-
项目类别:
-
资助金额:$11.81万
-
财政年份:1991
-
负责人:JEROME L AVORN
-
依托单位:
DRUG-INDUCED PARKINSONIAN SYMPTOMS IN THE ELDERLY
-
批准号:3121536
-
项目类别:
-
资助金额:$5.21万
-
财政年份:1991
-
负责人:JEROME L AVORN
-
依托单位:
TOPICAL B-BLOCKER SIDE EFFECTS IN ELDERLY
-
批准号:3264733
-
项目类别:
-
资助金额:$15.55万
-
财政年份:1989
-
负责人:JEROME L AVORN
-
依托单位:
IMPROVING THE ACCURACY OF TRANSFUSION DECISION MAKING
-
批准号:3442469
-
项目类别:
-
资助金额:$32.88万
-
财政年份:1988
-
负责人:JEROME L AVORN
-
依托单位:
IMPROVING THE ACCURACY OF TRANSFUSION DECISION MAKING
-
批准号:3442468
-
项目类别:
-
资助金额:$27.92万
-
财政年份:1988
-
负责人:JEROME L AVORN
-
依托单位:
STAFF EXPECTATION AS A MEDIATOR OF FUNCTIONAL STATUS
-
批准号:3380700
-
项目类别:
-
资助金额:$12.65万
-
财政年份:1987
-
负责人:JEROME L AVORN
-
依托单位:
STAFF EXPECTATION AS A MEDIATOR OF FUNCTIONAL STATUS
-
批准号:3380699
-
项目类别:
-
资助金额:$14.98万
-
财政年份:1987
-
负责人:JEROME L AVORN
-
依托单位:
MEDICATION USE AS A RISK FACTOR FOR FALLS IN THE ELDERLY
-
批准号:3117516
-
项目类别:
-
资助金额:$13.83万
-
财政年份:1986
-
负责人:JEROME L AVORN
-
依托单位:
MEDICATION USE AS A RISK FACTOR FOR FALLS IN THE ELDERLY
-
批准号:3117517
-
项目类别:
-
资助金额:$12.35万
-
财政年份:1986
-
负责人:JEROME L AVORN
-
依托单位:
IMPROVING THE ACCURACY OF TRANSFUSION DECISION MAKING
-
批准号:3442465
-
项目类别:
-
资助金额:$29.73万
-
财政年份:1985
-
负责人:JEROME L AVORN
-
依托单位:
STRATEGIES TO REDUCE INAPPROPRIATE USE OF BLOOD PRODUCTS
-
批准号:3442466
-
项目类别:
-
资助金额:$6.0万
-
财政年份:1985
-
负责人:JEROME L AVORN
-
依托单位:
STRATEGIES TO REDUCE INAPPROPRIATE USE OF BLOOD PRODUCTS
-
批准号:3442467
-
项目类别:
-
资助金额:$32.48万
-
财政年份:1985
-
负责人:JEROME L AVORN
-
依托单位:
STRATEGIES TO REDUCE INAPPROPRIATE USE OF BLOOD PRODUCTS
-
批准号:3442464
-
项目类别:
-
资助金额:$30.46万
-
财政年份:1985
-
负责人:JEROME L AVORN
-
依托单位: